✦ LIBER ✦

1101 THE EFFECT OF RENAL IMPAIRMENT AND END STAGE RENAL DISEASE ON THE SINGLE-DOSE PHARMACOKINETICS OF PSI-7977

✍ Scribed by Cornpropst, M.T.; Denning, J.M.; Clemons, D.; Marbury, T.C.; Alcorn, H.; Smith, W.B.; Sale, M.; Fang, L.; Berrey, M.M.; Symonds, W.T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of end stage renal disease and a

✍ PD Kroboth; RB Smith; MR Silver; R Rault; MI Sorkin; JB Puschett; RP Juhl 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

The Pharmacokinetics of Subcutaneous Eno

✍ Dr. Donald F. Brophy; Dr. Lori D. Wazny; Dr. Todd W. B. Gehr; Dr. Thomas J. Coms 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

The pharmacokinetics of aminoguanidine i

✍ Foote, Edward F.; Look, Zee M.; Giles, Penelope; Keane, William F.; Halstenson, 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 586 KB

The effect of haemodialysis on the pharm

✍ M. S. Al-Ghamdi; F. A. Al-Mohanna; Z. H. Al-Mustafa; I. S. Al-Saeed 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 332 KB

Effect of renal impairment on the pharma

✍ Helle Linnebjerg; Prajakti A. Kothare; Soomin Park; Kenneth Mace; Shobha Reddy; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

The pharmacokinetics of etanercept in pa

✍ Burl R. Don; Gregory Spin; Aubri Rose; Ivan Nestorov; Matt Hutmacher; George A. 📂 Article 📅 2005 🏛 Pharmaceutical Press 🌐 English ⚖ 265 KB